Targeting multiple signal transduction pathways in lung cancer.

Medicine & Life Sciences

• Lung Neoplasms 100%
• Signal Transduction 98%
• Phosphotransferases 97%
• AEE 788 49%
• ErbB Receptors 48%
• vatalanib 43%
• N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine 40%
• Axitinib 39%
• Proto-Oncogene Proteins c-raf 38%
• Platelet-Derived Growth Factor Receptors 33%
• Sunitinib 32%
• Sorafenib 31%
• Vascular Endothelial Growth Factor Receptor 30%
• src-Family Kinases 29%
• Cytoplasmic and Nuclear Receptors 25%
• Growth 25%
• Neoplasms 24%
• Protein Kinases 23%
• Intercellular Signaling Peptides and Proteins 20%
• Phosphorylation 17%
• Neoplasm Metastasis 15%
• Apoptosis 15%
• Membranes 15%
• Proteins 9%
• Therapeutics 8%